Cyprotex PLC acquired Apredica LLC in August 2010 as a way to further develop our toxicology offerings and expand our international reach to more readily provide the industry-leading in vitro ADME and in silico prediction services on which we built our reputation.
We are investing heavily in our US site and will be replicating our hugely successful high throughput ADME facility which we originally developed at our Macclesfield site. This facility is due to open in January 2014. As the service portfolios between the sites become more aligned, we feel that it is the right time to unify the brands under the Cyprotex name.
From a practical standpoint, very little is changing. Outwardly, the most noticeable impact will be that the Apredica website will no longer be accessible and all information on the company is now available on the Cyprotex website www.cyprotex.com.
There will be no service disruptions or slowdowns. If you have worked with Apredica previously, you will continue to experience the high quality service you are accustomed to. Quotes, proposals and invoices may look a little different, but the process you are familiar with will go unchanged.
We are very excited about Cyprotex’s plans for expansion and growth, and increasing Cyprotex brand recognition globally is one part of this growth strategy.
If you have any questions or concerns then we will be happy to address them. Please contact us at email@example.com
313 Pleasant St.
Watertown, MA 02472
Come visit us! Cyprotex is located in a 8,800 square foot facility on the third floor of 313 Pleasant St., Watertown, MA.
Cyprotex is located in Watertown, MA, which is immediately adjacent to the Cambridge, MA biotech hub.
Phone: +44 (0)1625 505100
15 Beech Lane